Floatz logo

Therapeutic Asset Ratings

154 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Carboplatin
Cervical Cancer
Merck Sharp & Dohme LLCP3B (62)
CIS-DIAMMINEDICHLOROPLATINUM II
Cervical Cancer
Uganda Cancer InstituteP3B (62)
Cyclophosphamide
Cervical Cancer
Merck Sharp & Dohme LLCP3B (62)
Epirubicin
Cervical Cancer
Merck Sharp & Dohme LLCP3B (62)
Pembrolizumab
Cervical Cancer
Merck Sharp & Dohme LLCP3B (62)
Indocyanine Green
Cervical Cancer
Istanbul UniversityP4B (61)
Irinotecan
Cervical Cancer
Merck Sharp & Dohme LLCP3B (60)
(+)-VINCRISTINE
Cervical Cancer
Merck Sharp & Dohme LLCP3B (59)
Docetaxel
Cervical Cancer
Laekna LimitedP2B (59)
Durvalumab
Cervical Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP2B (59)
Fludarabine
Cervical Cancer
City of Hope Medical CenterP2B (59)
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Cervical Cancer
National Cancer Institute (NCI)P3B (58)
FENTANYL
Cervical Cancer
National Cancer Institute (NCI)P3B (58)
FILGRASTIM
Cervical Cancer
University of California, IrvineP2B (58)
Benadryl
Cervical Cancer
National Cancer Institute (NCI)P3B (56)
HYDROMORPHON
Cervical Cancer
National Cancer Institute (NCI)P3B (56)
Ketorolac Tromethamine
Cervical Cancer
National Cancer Institute (NCI)P3B (56)
Sacituzumab Tirumotecan
Cervical Cancer
Merck Sharp & Dohme LLCP3B (56)
Atezolizumab
Cervical Cancer
KaliVir ImmunotherapeuticsP2B (56)
FLUOROURACILUM
Cervical Cancer
AstraZenecaP2B (56)
FLUTICASONE
Cervical Cancer
Mayo ClinicP2CCC (55)
pds0101
Cervical Cancer
Weill Medical College of Cornell UniversityP2CCC (55)
Sargramostim
Cervical Cancer
Mayo ClinicP2CCC (55)
TIL
Cervical Cancer
City of Hope Medical CenterP2CCC (55)
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-
Cervical Cancer
Sichuan Cancer Hospital and Research InstituteP3CCC (54)
Showing 1 to 25 of 154 assets
PreviousPage 1 of 7Next